Cyclerion Therapeutics, Inc.SEC Filings
|
|
All SEC filings by Cyclerion Therapeutics, Inc. (CYCN) — annual and quarterly reports, current reports, registrations, proxies and ownership forms, updated in real time.
Financials
| 10-Q | Quarterly report | View Diff | Aug 4, 2026 | |
| 10-Q | Quarterly report | View Diff | May 12, 2026 | |
| 10-K/A | Annual report | View Diff | Apr 30, 2026 | |
| 10-K | Annual report | View Diff | Mar 30, 2026 | |
| 10-Q | Quarterly report | View Diff | Nov 12, 2025 | |
| 10-K/A | Annual report | View Diff | Nov 12, 2025 | |
| 10-Q | Quarterly report | View Diff | Aug 5, 2025 | |
| 10-Q | Quarterly report | View Diff | May 6, 2025 | |
| 10-K | Annual report | View Diff | Mar 4, 2025 | |
| 10-Q | Quarterly report | View Diff | Nov 14, 2024 |
Events
| 8-K | Current report | Aug 27, 2026 | ||
| 8-K | Current report | Aug 25, 2026 | ||
| 8-K | Cyclerion Therapeutics and Korsana Biosciences Announce Merger Agreement | Apr 1, 2026 | ||
| 8-K | Cyclerion Therapeutics Announces Progress Toward Cyc-126 Phase 2 Proof-Of-Concept Study | Feb 17, 2026 | ||
| 8-K | Entry Into a Material Definitive Agreement | Jan 6, 2026 | ||
| 8-K | Current report | Dec 1, 2025 | ||
| 8-K | Cyclerion Announces Transformational Relaunch as a Neuropsychiatric Company | Sep 23, 2025 | ||
| 8-K | Current report | Jun 18, 2025 | ||
| 8-K | Current report | May 7, 2025 | ||
| 8-K | Current report | Mar 25, 2025 |
Registrations and Prospectuses
| 425 | Business combination disclosure | Aug 25, 2026 | ||
| 425 | Business combination disclosure | Aug 12, 2026 | ||
| 425 | Business combination disclosure | Aug 10, 2026 | ||
| 425 | Business combination disclosure | Aug 10, 2026 | ||
| 425 | Business combination disclosure | Aug 6, 2026 | ||
| 425 | Business combination disclosure | Aug 6, 2026 | ||
| 425 | Business combination disclosure | Aug 3, 2026 | ||
| 425 | Business combination disclosure | Aug 3, 2026 | ||
| 424B3 | Prospectus supplement | Jul 24, 2026 | ||
| S-4/A | Registration of securities issued in business combination transactions | View Diff | Jul 22, 2026 |
Proxies
| DEFA14A | Proxy Filing | Apr 29, 2025 | ||
| DEF 14A | Definitive proxy | View Diff | Apr 29, 2025 | |
| DEFA14A | Proxy Filing | Apr 29, 2024 | ||
| DEF 14A | Definitive proxy | View Diff | Apr 29, 2024 | |
| DEFM14A | Proxy related to merger | Jun 20, 2023 | ||
| PREM14A | Preliminary proxy related to merger | Jun 9, 2023 | ||
| DEFA14A | Annual Meeting of Shareholders | May 11, 2023 | ||
| DEFA14A | Proxy Filing | Apr 3, 2023 | ||
| DEF 14A | Definitive proxy | View Diff | Apr 3, 2023 | |
| PRE 14A | Preliminary proxy | Mar 22, 2023 |
Other
| EFFECT | Notice of effectiveness | Jul 27, 2026 | ||
| EFFECT | Notice of effectiveness | May 16, 2025 | ||
| CORRESP | Correspondence with SEC | May 13, 2025 | ||
| UPLOAD | Letter from SEC | May 12, 2025 | ||
| EFFECT | Notice of effectiveness | Feb 13, 2025 | ||
| CORRESP | Correspondence with SEC | Feb 10, 2025 | ||
| UPLOAD | Letter from SEC | Feb 7, 2025 | ||
| UPLOAD | Letter from SEC | Dec 28, 2023 | ||
| CORRESP | Correspondence with SEC | Dec 12, 2023 | ||
| UPLOAD | Letter from SEC | Nov 28, 2023 |